A Path to Precision Metabolic Treatment in Breast Cancer: Riluzole, Glutamate Signaling, and Invasive Lobular Carcinoma
J Endocr Soc
.
2023 Dec 26;8(2):bvad171.
doi: 10.1210/jendso/bvad171.
eCollection 2024 Jan 5.
Authors
Matthew J Sikora
1
,
Julie H Ostrander
2
Affiliations
1
Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
2
Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
PMID:
38193025
PMCID:
PMC10772494
DOI:
10.1210/jendso/bvad171
No abstract available
Keywords:
PET/CT; anti-estrogen; breast cancer; glutamate; invasive lobular carcinoma; metabolism.
Publication types
Comment